INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

Geneos Wealth Management Inc.'s Holding History (CIK: 0001764754)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 400 Value ($000) $7 Avg Close Range
Q2 2023
Shares 400 Value ($000) $4 Avg Close Range
Q1 2023
Shares 400 Value ($000) $5 Avg Close Range
Q4 2022
Shares 400 Value ($000) $5 Avg Close Range
Q3 2022
Shares 400 Value ($000) $5 Avg Close Range
Q2 2022
Shares 400 Value ($000) $5 Avg Close Range
Q1 2022
Shares 400 Value ($000) $6 Avg Close Range
Q4 2021
Shares 400 Value ($000) $6 Avg Close Range
Q3 2021
Shares 400 Value ($000) $6 Avg Close Range
Q2 2021
Shares 400 Value ($000) $7 Avg Close Range
Q1 2021
Shares 400 Value ($000) $7 Avg Close Range
Q4 2020
Shares 400 Value ($000) $9 Avg Close Range
Q3 2020
Shares 400 Value ($000) $16 Avg Close Range
Q2 2020
Shares 400 Value ($000) $30 Avg Close Range
Q1 2020
Shares 400 Value ($000) $26 Avg Close Range
Q4 2019
Shares 400 Value ($000) $49 Avg Close Range
Q3 2019
Shares 400 Value ($000) $25 Avg Close Range
Q2 2019
Shares 400 Value ($000) $31 Avg Close Range
Q1 2019
Shares 400 Value ($000) $44 Avg Close Range
Q4 2018
Shares 600 Value ($000) $56 Avg Close Range
Q3 2018
Shares 500 Value ($000) $63 Avg Close Range
Q2 2018
Shares 400 Value ($000) $33 Avg Close Range
Q1 2018
Shares 400 Value ($000) $24 Avg Close Range
Q4 2017
Shares 400 Value ($000) $23 Avg Close Range
Q3 2017
Shares 400 Value ($000) $23 Avg Close Range